Citation Redman CWG, Sargent IL. Immunology of Pre‐eclampsia. Am J Reprod Immunol
2010 Pre‐eclampsia develops in stages, only the last being the clinical illness. This is …

Protein oxidation is involved in regulatory physiological events as well as in damage to
tissues and is thought to play a key role in the pathophysiology of diseases and in the aging …

Extensive evidence suggests that the release of membrane-enclosed compartments, more
commonly known as extracellular vesicles (EVs), is a potent newly identified mechanism of …

Worldwide the prevalence of preeclampsia (PE) ranges from 3 to 8% of pregnancies. 8.5
million cases are reported yearly, but this is probably an underestimate due to the lack of …

Preeclampsia is a leading cause of pregnancy complications and affects 3–7% of pregnant
women. This review summarizes the current knowledge of a new potential etiology of the …

An unavoidable consequence of aerobic respiration is the generation of reactive oxygen
species (ROS). These may negatively impact development. Nevertheless, a certain amount …

Although the precise pathophysiology of pre-eclampsia remains unknown, this condition
continues to be a major cause of maternal and fetal mortality. Early prediction of pre …

α1-microglobulin (A1M) is found in all vertebrates including humans. A1M was, together with
retinol-binding protein and β-lactoglobulin, one of the three original lipocalins when the …

Studies about oxidative stress biomarkers revealed different phenotypes between early and
late preeclampsia (PE). Despite that, there is extensive evidence of oxidative stress in …

Background Preeclampsia (PE) is a complex pregnancy syndrome characterised by
maternal hypertension and organ damage after 20 weeks of gestation and is associated with …